Home > Income Statement > TORRENT PHARMACEUTICALS

TORRENT PHARMACEUTICALS
Revenue

    Back to Income Statement
TORRENT PHARMACEUTICALS is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for TORRENT PHARMACEUTICALS
Please provide your vote to see the results

TORRENT PHARMACEUTICALS Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Net Sales ₹10,728 Cr₹9,620 Cr₹8,508 Cr₹8,005 Cr₹7,939 Cr

What is the latest Revenue of TORRENT PHARMACEUTICALS ?

The latest Revenue ratio of TORRENT PHARMACEUTICALS is ₹10,728 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹10,728 Cr
Mar2024₹9,620 Cr
Mar2023₹8,508 Cr
Mar2022₹8,005 Cr
Mar2021₹7,939 Cr

How is Revenue of TORRENT PHARMACEUTICALS Trending?

Years Revenue % Change
Mar2025 ₹10,728 Cr
11.51
Mar2024 ₹9,620 Cr
13.07
Mar2023 ₹8,508 Cr
6.29
Mar2022 ₹8,005 Cr
0.82
Mar2021 ₹7,939 Cr -

Compare Revenue of peers of TORRENT PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS ₹129,026.8 Cr 0.3% 1.6% 12.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹412,494.0 Cr -1.5% -4.8% -4.2% Stock Analytics
DIVIS LABORATORIES ₹170,514.0 Cr -0.9% -1.4% 11.1% Stock Analytics
CIPLA ₹121,574.0 Cr -0.8% -1.2% 1.4% Stock Analytics
DR REDDYS LABORATORIES ₹105,919.0 Cr -0.8% 1.7% -5.6% Stock Analytics
MANKIND PHARMA ₹90,491.0 Cr 0.8% -3% -26.9% Stock Analytics


TORRENT PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
TORRENT PHARMACEUTICALS

0.3%

1.6%

12.1%

SENSEX

0.7%

0.5%

9%


You may also like the below Video Courses